| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/26/2013 | WO2013141092A1 Cancer metastasis marker and method for diagnosing cancer metastasis using same |
| 09/26/2013 | WO2013140389A1 Plif multimeric peptides and uses thereof |
| 09/26/2013 | WO2013140247A1 Antibodies that neutralize rsv, mpv and pvm and uses thereof |
| 09/26/2013 | WO2013139988A1 New method of dynamic spectroscopy under physiological conditions |
| 09/26/2013 | WO2013139968A1 NOVEL ANTIBODIES ANTI-sPLA2-IIA AND USES THEREOF |
| 09/26/2013 | WO2013139956A1 Antibodies abrogating cell binding to lactadherin |
| 09/26/2013 | WO2013139803A1 Carbohydrate-glycolipid conjugate vaccines |
| 09/26/2013 | WO2013139789A1 B-cell receptor complex binding proteins containing t-cell epitopes |
| 09/26/2013 | WO2013139701A1 Method and pharmaceutical composition for use in the treatment or the prevention of aneurysm |
| 09/26/2013 | WO2013139340A1 Hcv full-length genotype 2b consensus clone |
| 09/26/2013 | WO2013115410A3 Anti-phospholipase d4 antibody |
| 09/26/2013 | WO2013090635A3 Composition and method for the diagnosis and treatment of iron-related disorders |
| 09/26/2013 | WO2013052174A3 Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
| 09/26/2013 | WO2012154994A3 A novel adenovirus isolated from titi monkeys |
| 09/26/2013 | WO2012031273A9 Novel modulators and methods of use |
| 09/26/2013 | US20130254912 Interferon alpha antibodies and their uses |
| 09/26/2013 | US20130253382 Targeted enzymatic degradation of quorum-sensing peptides |
| 09/26/2013 | US20130253175 Gram-positive bacteria specific binding compounds |
| 09/26/2013 | US20130253174 Monoclonal antibody against slightly oxidized low-density lipoprotein and hybridoma for producing the same |
| 09/26/2013 | US20130253173 Antibodies That Are Capable of Specifically Binding Tissue Factor Pathway Inhibitor |
| 09/26/2013 | US20130253172 Method for Making Heteromultimeric Molecules |
| 09/26/2013 | US20130252840 Liquid tissue preparation from histopathologically processed biologically samples, tissues and cells |
| 09/26/2013 | US20130252326 Frizzled-binding agents and uses thereof |
| 09/26/2013 | US20130251736 Methods for reducing granulomatous inflammation |
| 09/26/2013 | US20130251733 Anti-cxcr3 antibodies |
| 09/26/2013 | US20130251729 Human monoclonal antibodies that bind cxcr4 and uses thereof |
| 09/26/2013 | US20130251726 Novel hiv -1 broadly neutralizing antibodies |
| 09/26/2013 | US20130251724 Antigen binding proteins to oncostatin m (osm) |
| 09/26/2013 | US20130251723 Anti-ror1 antibodies |
| 09/26/2013 | US20130251722 Antibodies Against Tissue Factor Pathway Inhibitor |
| 09/26/2013 | US20130251721 Antibodies Against Tissue Factor Pathway Inhibitor |
| 09/26/2013 | US20130251720 Novel compositions and methods for the treatment of immune related diseases |
| 09/26/2013 | US20130251718 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/26/2013 | US20130251717 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/26/2013 | US20130251716 Antibodies that bind il-4 and/or il-13 and their uses |
| 09/26/2013 | US20130251715 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 09/26/2013 | US20130251714 Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use |
| 09/26/2013 | US20130251712 Covalently dimerized bivalent binding agents |
| 09/26/2013 | US20130251708 Anti-psgl-1 antibodies and uses thereof |
| 09/26/2013 | US20130251707 ANTI-huTNFR1 ANTIBODY |
| 09/26/2013 | US20130251705 Compositions and methods for diagnosing and treating cancer |
| 09/26/2013 | US20130251704 Monoclonal antibodies against orthopoxviruses |
| 09/26/2013 | US20130251703 Antibodies for epidermal growth factor receptor 3 (her3) directed to domain iii and domain iv of her3 |
| 09/26/2013 | US20130251672 Method and system to remove soluble tnfr1, tnfr2 and il2 in patients |
| 09/26/2013 | US20130251642 Chimeric rabbit/human ror1 antibodies |
| 09/25/2013 | EP2641919A2 Antigen-binding constructs |
| 09/25/2013 | EP2641918A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 09/25/2013 | EP2641917A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 09/25/2013 | EP2641916A1 Novel antibodies anti-sPLA2-IIA and uses thereof |
| 09/25/2013 | EP2641915A1 Antibodies to the chemokine receptor XCR1 |
| 09/25/2013 | EP2641914A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same |
| 09/25/2013 | EP2641913A2 Immunoglobulin constant region Fc receptor binding agents |
| 09/25/2013 | EP2641912A1 Process for obtaining an IgG composition through heat treatment |
| 09/25/2013 | EP2641618A2 Humanized anti-CD79B antibodies and immunoconjugates and methods of use |
| 09/25/2013 | EP2641612A1 Alpha 5 - beta 1 antibodies and their uses |
| 09/25/2013 | EP2640832A1 New ethiological agent |
| 09/25/2013 | EP2640750A1 Agents and methods for treating diseases that correlate with bcma expression |
| 09/25/2013 | EP2640749A1 Silent fc variants of anti-cd40 antibodies |
| 09/25/2013 | EP2640748A1 Luteinizing-hormone ligand and ligand-gonadotrophin complex |
| 09/25/2013 | EP2640747A1 Antibody with specificity for gm-csf (ii) |
| 09/25/2013 | EP2640746A1 Antibody with specificity for gm-csf (i) |
| 09/25/2013 | EP2640745A2 Antibody derivatives |
| 09/25/2013 | EP2640744A2 Neutralizing anti-ccl20 antibodies |
| 09/25/2013 | EP2640743A2 Methods for producing recombinant proteins |
| 09/25/2013 | EP2640742A1 A collection and methods for its use |
| 09/25/2013 | EP2640421A1 Regimens for treatments using anti-igf antibodies |
| 09/25/2013 | EP2640416A1 Combination therapy for b cell lymphomas |
| 09/25/2013 | EP2520589A9 Anti-cd27 antibody |
| 09/25/2013 | CN103328632A Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
| 09/25/2013 | CN103328514A Protein complexes for antigen binding and methods of use |
| 09/25/2013 | CN103328513A Anti CCR4 antibodies and uses thereof |
| 09/25/2013 | CN103328512A CXCR2 binding polypeptides |
| 09/25/2013 | CN103328511A Anti-Il-1 beta antibodies and methods of use |
| 09/25/2013 | CN103328510A Luteinizing-hormone ligand and ligand-gonadotrophin complex |
| 09/25/2013 | CN103328509A Method for measuring human insulin and measurement reagent |
| 09/25/2013 | CN103328508A Antigen binding proteins |
| 09/25/2013 | CN103328507A ALPHABODY libraries and methods for producing the same |
| 09/25/2013 | CN103328506A Therapies for improving pulmonary function |
| 09/25/2013 | CN103328505A Non-antagonistic EGFR-binding molecules and immunoconjugates thereof |
| 09/25/2013 | CN103328500A Methods and compounds for the diagnosis and treatment |
| 09/25/2013 | CN103320460A E3 protein used for detection of sheep-pox virus and hyper-immune serum thereof |
| 09/25/2013 | CN103320428A Directional immobilization method of single-chain antibody by covalent bonds using carbohydrate chain labels |
| 09/25/2013 | CN103320391A Hybridoma cell and application thereof |
| 09/25/2013 | CN103319600A Humanized anti-TLR4 antibody Fab as well as preparation method and application thereof |
| 09/25/2013 | CN103319599A Anti-human ErbB2 antibody-ansamitocin conjugate and applications thereof |
| 09/25/2013 | CN103319598A Insulin-like growth factor-1 receptor (IGF-1R) resistant antibody and coding genes and applications thereof |
| 09/25/2013 | CN103319597A Insulin-like growth factor-1 receptor (IGF-1R) resistant antibody and coding genes and applications thereof |
| 09/25/2013 | CN103319596A Compositions and methods for increasing bone mineralization |
| 09/25/2013 | CN103319595A Preparation method and application of anti-human alpha fetoprotein (AFP) single-chain antibody and fusion antigen peptide |
| 09/25/2013 | CN103319594A Cancer diagnostic kit containing monoclonal antibody AntiDaintain and usage thereof |
| 09/25/2013 | CN103319593A Anti StxII monoclonal antibody |
| 09/25/2013 | CN103319592A Process for obtaining an IgG composition through heat treatment |
| 09/25/2013 | CN103319591A Preparation of complete antigen and monoclonal antibody of gonyatoxine GTX2,3 |
| 09/25/2013 | CN103319571A Nasopharyngeal carcinoma radiotherapy-sensitive polypeptide marker SPG03 and ELISA kit thereof |
| 09/25/2013 | CN102876634B PMSG (pregnant mare serum gonadotropin) double-antibody sandwich ELISA (enzyme-linked immunosorbent assay) kit |
| 09/25/2013 | CN102861333B High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken |
| 09/25/2013 | CN102453091B Tetanus toxoid monoclonal antibody and preparation method and application thereof |
| 09/25/2013 | CN102174105B Antibodies directed to HER-3 and uses thereof |
| 09/25/2013 | CN101982777B Duck plague virus antigen capturing ELISA method based on anti-recombination UL51 albumen antibody |
| 09/25/2013 | CN101955538B Anti-streptomycin antibody and application thereof |